Aa
Aa
A
A
A
Close
Avatar universal

C-erb-B2 mutation

What is known by C-erb-B2 mutationa and breast cancer.
Is it good to continue the treatment with Nolvadex after 5 years.

Thanks
2 Responses
Sort by: Helpful Oldest Newest
Avatar universal
Thank you for the quick answer.  I inform my patient.
God bless you too.
Helpful - 0
Avatar universal
Hi there.

The amplification of the cERBB2 gene in breast cancer cells is associated with a more aggressive cancer phenotype.  This gene is amplified in about 20 - 30% of cases.  At the present though, two drugs already target the overexpressed protein.  These drugs are Herceptin and Lapatinib and has been shown to improve outcomes in breast cancer patients.

The benefit of hormonal treatment beyond 5 years is only demonstrated with the drug Femara (MA17 study) and I'm not aware of similar trials involving Novladex.

Regards and God bless.
Helpful - 0
Have an Answer?

You are reading content posted in the Breast Cancer Community

Didn't find the answer you were looking for?
Ask a question
Popular Resources
A quick primer on the different ways breast cancer can be treated.
Diet and digestion have more to do with cancer prevention than you may realize
From mammograms to personal hygiene, learn the truth about these deadly breast cancer rumors.
Breast cancer is not an inevitability. From what you eat and drink to how much you exercise, learn what you can do to slash your risk.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.